Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

In vitro effects of oestrogens, antioestrogens and SERMs on pancreatic solid pseudopapillary neoplasm-derived primary cell culture.

Tognarini I, Tonelli F, Nesi G, Martineti V, Galli G, Gozzini A, Colli E, Zonefrati R, Paglierani M, Marini F, Sorace S, Cavalli T, Cavalli L, Tanini A, Brandi ML.

Cell Oncol. 2010;32(5-6):331-43. doi: 10.3233/CLO-2010-0522.

2.

Selective estrogen-receptor modulators suppress microglial activation and neuronal cell death via an estrogen receptor-dependent pathway.

Ishihara Y, Itoh K, Ishida A, Yamazaki T.

J Steroid Biochem Mol Biol. 2015 Jan;145:85-93. doi: 10.1016/j.jsbmb.2014.10.002. Epub 2014 Oct 8.

PMID:
25305410
3.

Characterization of new estrogen receptor destabilizing compounds: effects on estrogen-sensitive and tamoxifen-resistant breast cancer.

Hoffmann J, Bohlmann R, Heinrich N, Hofmeister H, Kroll J, Künzer H, Lichtner RB, Nishino Y, Parczyk K, Sauer G, Gieschen H, Ulbrich HF, Schneider MR.

J Natl Cancer Inst. 2004 Feb 4;96(3):210-8.

PMID:
14759988
4.
5.
6.

Effects of SERM (selective estrogen receptor modulator) treatment on growth and proliferation in the rat uterus.

Stygar D, Muravitskaya N, Eriksson B, Eriksson H, Sahlin L.

Reprod Biol Endocrinol. 2003 May 7;1:40.

7.

Oestrogens and selective oestrogen receptor (ER) modulators regulate EGF receptor gene expression through human ER alpha and beta subtypes via an Sp1 site.

Salvatori L, Pallante P, Ravenna L, Chinzari P, Frati L, Russo MA, Petrangeli E.

Oncogene. 2003 Jul 31;22(31):4875-81.

PMID:
12894229
8.

Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.

Katzenellenbogen BS, Choi I, Delage-Mourroux R, Ediger TR, Martini PG, Montano M, Sun J, Weis K, Katzenellenbogen JA.

J Steroid Biochem Mol Biol. 2000 Nov 30;74(5):279-85. Review.

PMID:
11162936
9.

Approaches targeted to estrogen receptors for treatment of tamoxifen-resistant breast cancer: a brief overview.

Terakawa N.

Oncology. 2000;59 Suppl 1:3-4. Review. No abstract available.

PMID:
11096349
10.

Estrogen receptor beta/alpha ratio predicts response of pancreatic cancer cells to estrogens and phytoestrogens.

Konduri S, Schwarz RE.

J Surg Res. 2007 Jun 1;140(1):55-66. Epub 2007 Feb 1.

PMID:
17275032
11.

Targeting estrogen receptor-α reduces adrenocortical cancer (ACC) cell growth in vitro and in vivo: potential therapeutic role of selective estrogen receptor modulators (SERMs) for ACC treatment.

Sirianni R, Zolea F, Chimento A, Ruggiero C, Cerquetti L, Fallo F, Pilon C, Arnaldi G, Carpinelli G, Stigliano A, Pezzi V.

J Clin Endocrinol Metab. 2012 Dec;97(12):E2238-50. doi: 10.1210/jc.2012-2374. Epub 2012 Oct 16.

PMID:
23074235
12.

Solid-pseudopapillary neoplasms of the pancreas in men and women: do they differ?

Takahashi Y, Hiraoka N, Onozato K, Shibata T, Kosuge T, Nimura Y, Kanai Y, Hirohashi S.

Virchows Arch. 2006 May;448(5):561-9. Epub 2006 Mar 8.

PMID:
16523258
13.

Estrogen-mediated mechanisms to control the growth and apoptosis of breast cancer cells: a translational research success story.

McDaniel RE, Maximov PY, Jordan VC.

Vitam Horm. 2013;93:1-49. doi: 10.1016/B978-0-12-416673-8.00007-1. Review.

PMID:
23810002
14.

Sensitivity of human melanoma cells to oestrogens, tamoxifen and quercetin: is there any relationship with type I and II oestrogen binding site expression?

Lama G, Angelucci C, Bruzzese N, Iacopino F, Nori SL, D'Atri S, Turriziani M, Bonmassar E, Sica G.

Melanoma Res. 1998 Aug;8(4):313-22. Erratum in: Melanoma Res 1999 Oct;9(5):530.

PMID:
9764806
15.

Pomegranate extract demonstrate a selective estrogen receptor modulator profile in human tumor cell lines and in vivo models of estrogen deprivation.

Sreeja S, Santhosh Kumar TR, Lakshmi BS, Sreeja S.

J Nutr Biochem. 2012 Jul;23(7):725-32. doi: 10.1016/j.jnutbio.2011.03.015. Epub 2011 Aug 11.

PMID:
21839626
16.

Anatomically-specific actions of oestrogen receptor in the developing female rat brain: effects of oestradiol and selective oestrogen receptor modulators on progestin receptor expression.

Gonzales KL, Quadros-Mennella P, Tetel MJ, Wagner CK.

J Neuroendocrinol. 2012 Feb;24(2):285-91. doi: 10.1111/j.1365-2826.2011.02232.x.

17.

Frequent beta-catenin mutation and cytoplasmic/nuclear accumulation in pancreatic solid-pseudopapillary neoplasm.

Tanaka Y, Kato K, Notohara K, Hojo H, Ijiri R, Miyake T, Nagahara N, Sasaki F, Kitagawa N, Nakatani Y, Kobayashi Y.

Cancer Res. 2001 Dec 1;61(23):8401-4.

18.

Effects of 4-hydroxytamoxifen, raloxifene and ICI 182 780 on survival of uterine cancer cell lines in the presence and absence of exogenous estrogens.

Leblanc K, Sexton E, Parent S, Bélanger G, Déry MC, Boucher V, Asselin E.

Int J Oncol. 2007 Feb;30(2):477-87.

PMID:
17203231
19.

Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors alpha and beta.

Tee MK, Rogatsky I, Tzagarakis-Foster C, Cvoro A, An J, Christy RJ, Yamamoto KR, Leitman DC.

Mol Biol Cell. 2004 Mar;15(3):1262-72. Epub 2003 Dec 29.

20.

Supplemental Content

Support Center